4//SEC Filing
DUNN JOHN MICHAEL 4
Accession 0001654954-17-008688
CIK 0001069308other
Filed
Sep 20, 8:00 PM ET
Accepted
Sep 21, 5:25 PM ET
Size
7.3 KB
Accession
0001654954-17-008688
Insider Transaction Report
Form 4
DUNN JOHN MICHAEL
Director
Transactions
- Other
Nonqualified Stock Option (right to buy)
2017-09-19+16,000→ 16,000 totalExercise: $2.55Exp: 2025-10-19→ Common Stock (16,000 underlying) - Other
Common Stock
2017-09-19+5,952→ 5,952 total
Footnotes (3)
- [F1]Received in connection with the Issuer's business combination (the "Merger") with what was then known as "Acer Therapeutics Inc." ("Private Acer") in accordance with the terms of the Agreement and Plan of Merger and Reorganization dated June 30, 2017 among the Issuer, Opexa Merger Sub, Inc. and Private Acer, in exchange for 5,952 shares of common stock of Private Acer.
- [F2]Received in connection with the Merger in exchange for an option to acquire 16,000 shares of common stock of Private Acer.
- [F3]Option vests in eight equal quarterly installments beginning on October 19, 2015.
Documents
Issuer
Acer Therapeutics Inc.
CIK 0001069308
Entity typeother
Related Parties
1- filerCIK 0001238648
Filing Metadata
- Form type
- 4
- Filed
- Sep 20, 8:00 PM ET
- Accepted
- Sep 21, 5:25 PM ET
- Size
- 7.3 KB